Page last updated: 2024-11-07

mdl 73404

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MDL 73404: structure given in first source; a hydrophilic cardioselective free radical scavenger; analog of alpha-tocopherol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131231
CHEMBL ID99134
SCHEMBL ID9096216
MeSH IDM0184257

Synonyms (11)

Synonym
CHEMBL99134
mdl 74,405
mdl 74405
130573-32-9
3,4-dihydro-6-hydroxy-n,n,n,2,5,7,8-heptamethyl-2h-1-benzopyran-2-ethanaminium 4-methylbenzenesulfonate
mdl-73404
mdl 73404
2h-1-benzopyran-2-ethanaminium, 3,4-dihydro-6-hydroxy-n,n,n,2,5,7,8-heptamethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
dhhbe
SCHEMBL9096216
2-(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)ethyl-trimethylazanium;4-methylbenzenesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID117989Percentage number of paraparetic mice 1 hr after concussive head injury1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
2,3-Dihydro-1-benzofuran-5-ols as analogues of alpha-tocopherol that inhibit in vitro and ex vivo lipid autoxidation and protect mice against central nervous system trauma.
AID195554The IC50 value was measured for inhibition of lipid autoxidation in rat brain homogenate.1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
AID16876The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
AID140142The in vitro IC50 value was measured for inhibition of lipid autoxidation in mouse heart homogenate1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
AID140145The ex vivo ID50 value was measured for inhibition of lipid autoxidation in mouse heart homogenate 1 hr after subcutaneous administration.1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
AID195549In vitro inhibition of lipid autoxidation (TBARS formation) of rat brain homogenate1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
2,3-Dihydro-1-benzofuran-5-ols as analogues of alpha-tocopherol that inhibit in vitro and ex vivo lipid autoxidation and protect mice against central nervous system trauma.
AID230782Superoxyl radical (O2) scavenging reaction rate constant in competition with nitro-blue tetrazolium of superoxyl radicals formed by xanthine oxidase in the presence of xanthine1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
2,3-Dihydro-1-benzofuran-5-ols as analogues of alpha-tocopherol that inhibit in vitro and ex vivo lipid autoxidation and protect mice against central nervous system trauma.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's18 (94.74)18.2507
2000's1 (5.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.10 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]